ultrasound-monitored changes in achilles tendinopathy after extracorporeal shock wave therapy

Conditions: Achilles Tendinopathy

Summary: this study is designed as a randomized, placebo-controlled clinical trial in which we monitor the effects of low-energy focused extracorporeal shockwave therapy (eswt) in patients with achilles tendinopathy (at). participants will be randomly divided into two groups. eswt according to selected parameters will be applied to group a. group b will receive sham eswt. patients in both groups will have the same program. the research for one patient lasts a total of 8 weeks (2 months) from the initial to the final examination. in the first week, there will be a clinical examination by a physiotherapist, an ultrasonographic examination, and the patient will complete a visa-a questionnaire. at the end of the examination, the patient will be randomly assigned to group a or b and receive the first application. for the next 4 weeks, additional applications will be performed once a week. the interval between individual applications should be at least 7 days. thus, a total of 5 applications of eswt or sham eswt will be performed. the final examination will take place 3 weeks after the last application and will include the same procedures as for the initial examination.

this study is designed as a randomized, placebo-controlled clinical trial in which we monitor the effects of low-energy focused extracorporeal shockwave therapy (eswt) in patients with achilles tendinopathy (at). participants will be randomly divided into two groups. eswt according to selected parameters will be applied to group a. group b will receive sham eswt. patients in both groups will have the same program. the research for one patient lasts a total of 8 weeks (2 months) from the initial to the final examination. in the initial session, there will be a clinical examination by a physiotherapist, which includes case history questions, measuring range of motion (measured by weight-bearing lunge test), functional loading tests (1-leg heel rise test, 1-leg hop test) and an ultrasonographic examination (tendon cross section area and width at the maximal tendon antero-posterior width place). in addition, the patient will complete a visa-a questionnaire. at the end of the initial session, the patient will be randomly assigned to group a or b and receive the first application. for the next 4 weeks, additional applications will be performed once a week. the interval between individual applications should be at least 7 days. thus, a total of 5 applications of eswt or sham eswt will be performed. the final examination will take place 3 weeks after the last application and will include the same procedures as for the initial examination.

Eligibility criteria:
inclusion criteria: * the patient complains about achilles tendon pain, which limits (at least partially) his quality of life during daily activities or sport, and this condition would be referred as a tendinopathy * the patient's other leg is asymptomatic * the patient is not aware of the symptomatical mechanical tendon damage in past (eg. partial or complete rupture due to injury) * the patient has no previous experience with extracorporeal shockwave therapy treatment exclusion criteria: * the patient has condition which is contraindication for extracorporeal shock wave therapy treatment * the patient had symptomatical mechanical tendon damage in past (eg. partial or complete rupture due to injury)

Keywords: extracorporeal shock wave therapy achilles tendinopathy ultrasonography